InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12

Management to host conference call and webcast at 8:30am ET

Tel Aviv, Israel— November 5, 2019 – InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, November 12, 2019, to discuss financial results for the third quarter and nine months ended September 30, 2019, and provide a corporate update.


Conference Call & Webcast:

Tuesday, November 12th @ 8:30am Eastern Time

Within the US:                                   877-451-6152

Outside the US:                                 201-389-0879

Conference ID:                                  13695583



About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet™® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.


InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.



Investor Contacts:

Craig Shore

Chief Financial Officer

InspireMD, Inc.



Jeremy Feffer

LifeSci Advisors, LLC